The company said the FDA gave it a 510(k) clearance for the use of Propeller, which combines sensors attached to inhalers with an app, with AstraZeneca's Symbicort, for patients with asthma and COPD.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,